Pharming N.V.(PHAR) - 2023 Q3 - Earnings Call Presentation
| --- | --- | |-------|-------------------------------------------------------------------------------------------------------------------------------------------| | | | | | Performed well in leading revenue indicators in the U.S. including active patients, vials shipped, and number of physicians prescribing | | | Strong U.S. in-market demand – over 70 new patient enrollments for 3 straight quarters | | | | | | On track for low single digit revenue growth for 2023 | Strong commitment to HAE community 700 20 ...